CytomX Therapeutics (CTMX) Receivables - Net (2016 - 2025)
Historic Receivables - Net for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to $1.6 million.
- CytomX Therapeutics' Receivables - Net fell 5140.21% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 5140.21%. This contributed to the annual value of $3.1 million for FY2024, which is 958.62% down from last year.
- CytomX Therapeutics' Receivables - Net amounted to $1.6 million in Q3 2025, which was down 5140.21% from $1.9 million recorded in Q2 2025.
- In the past 5 years, CytomX Therapeutics' Receivables - Net registered a high of $36.0 million during Q4 2022, and its lowest value of $756000.0 during Q1 2021.
- In the last 5 years, CytomX Therapeutics' Receivables - Net had a median value of $1.9 million in 2025 and averaged $4.2 million.
- As far as peak fluctuations go, CytomX Therapeutics' Receivables - Net tumbled by 9941.85% in 2021, and later skyrocketed by 445518.99% in 2022.
- Quarter analysis of 5 years shows CytomX Therapeutics' Receivables - Net stood at $790000.0 in 2021, then soared by 4455.19% to $36.0 million in 2022, then crashed by 90.46% to $3.4 million in 2023, then fell by 9.59% to $3.1 million in 2024, then tumbled by 47.5% to $1.6 million in 2025.
- Its Receivables - Net stands at $1.6 million for Q3 2025, versus $1.9 million for Q2 2025 and $2.0 million for Q1 2025.